Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Knowledge of the specific aspects of sepsis in patients with cancer may improve cancer care and guide future research on targeted sepsis therapies.
Authors
- Marit G Husby (ORCID: https://orcid.org/0009-0008-4947-2339)
- Lise Tuset Gustad (ORCID: https://orcid.org/0000-0003-2709-3991)
- Anne‐Sofie Furberg (ORCID: https://orcid.org/0000-0002-6311-166X)
- Hanne Frydenberg (ORCID: https://orcid.org/0009-0003-4976-9099)
- Inger Thune (ORCID: https://orcid.org/0009-0003-9598-104X)
- Erik Solligård (ORCID: https://orcid.org/0000-0001-6173-3580)
- Nina Vibeche Skei (ORCID: https://orcid.org/0000-0002-6931-007X)
- Tor Åge Myklebust (ORCID: https://orcid.org/0000-0003-4645-1635)
Institutions
- Oslo University Hospital (NO)
- University Hospital of North Norway (NO)
- Norwegian Institute of Public Health (NO)
- Molde University College (NO)
- University of Oslo (NO)
- School of the Art Institute of Chicago (US)
- Norwegian University of Science and Technology (NO)
- Levanger Hospital (NO)
- Nord University (NO)
- Molde Hospital (NO)
- Ålesund Hospital (NO)
- St Olav's University Hospital (NO)
- Cancer Registry of Norway (NO)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-1018
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00